Preview

Medical alphabet

Advanced search
Open Access Open Access  Restricted Access Subscription or Fee Access

Electrotherapy in the Combined Treatment of Patients with Chronic Migraine and Cervicalgia

https://doi.org/10.33667/2078-5631-2024-33-47-50

Abstract

Chronic Migraine and Cervicalgia Significantly Impact Patients’ Quality of Life. Botulinum Therapy is an Effective Treatment, but Its Limited Efficacy as Monotherapy Necessitates the Development of Combined Approaches.

Objective. To compare the effectiveness of botulinum therapy and its combination with electrotherapy in patients with chronic migraine and cervicalgia.

Materials and Methods. The study included 58 patients divided into two groups: the first group (n = 30) received botulinum therapy, while the second group (n = 28) underwent electrotherapy combined with botulinum therapy. Pain severity was assessed before treatment, and at 1 and 3 months after therapy initiation.

Results. After a month of treatment, in group II there was a significant decrease in the frequency of headache attacks, cervicalgia and the number of analgesics taken compared to group I. After 3 months, scores continued to improve, with no significant difference between groups.

Conclusions. The combined use of electrotherapy and botulinum therapy effectively reduces pain at all stages of observation.

About the Author

V. M. Soskin
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Soskin Viktor M., Postgraduate student, Department of Sports Medicine and Medical Rehabilitation, N.V. Sklifosovsky Institute of Clinical Medicine, Sechenov University



References

1. Azimova Yu.E., Amelin A.V., Alferova V.V. et al. Clinical guidelines «Migraine». S.S. Korsakov Journal of Neurology and Psychiatry. 2022; 122 (1-3): 4-36. (In Russ.). https://doi. org/10.17116/jnevro20221220134

2. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018 Jan; 38 (1): 1-211. https://doi.org/10.1177/0333102417738202 PMID: 29368949

3. Naprienko M.V., Safonov M.I., Surnova E.A., Smekalkina L.V. Chances of manual therapy in rehabilitation of chronic migraine. Medical alphabet. 2018; 3 (27): 27-29. (In Russ.).

4. Chernenko A., Dubenko O., Kovalenko L., Nessonova T. Co-occurring neck-pain with myofascial dysfunction in patients with episodic migrainE. Wiad Lek. 2022; 75 (2): 433-437. PMID: 35307672.

5. Hovaguimian A., Roth J. Management of chronic migraine. BMJ. 2022 Oct 10; 379: e067670. https://doi.org/10.1136/bmj2021-067670. PMID: 36216384.

6. Tabeeva G.R., Filatova E.G., Amelin A.V., Osipova V.V., Artemenko A.R., Akhmadeeva L.R., Ekusheva E.V., Koreshkina M.I., Lebedeva E.R., Sergeev A.V., Golovacheva V.A., Latysheva N. V., Naprienko M. V., Skorobogatykh K. V., Azimova Yu.E., Rachin A. P., Parfenov V.A. Alternative and complementary treatments for migraine. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. (In Russ.). 2024; 16 (1): 4-15. DOI: 10.14412/2074271120241415

7. Cashin AG, Wand BM, O'Connell NE, Lee H, Rizzo RR, Bagg MK, O'Hagan E, Maher CG, Furlan AD, van Tulder MW, McAuley JH. Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2023 Apr 4; 4 (4): CD013815. DOI: 10.1002/14651858.CD013815.pub2. PMID: 37014979; PMCID: PMC10072849.

8. Corp N, Mansell G, Stynes S, Wynne-Jones G, Morsø L, Hill JC, van der Windt DA. Evidence-based treatment recommendations for neck and low back pain across Europe: A systematic review of guidelines. Eur J Pain. 2021 Feb; 25 (2): 275-295. https://doi.org/10.1002/ejp.1679. Epub 2020 Nov 12. PMID: 33064878; PMCID: PMC7839780.

9. Artemenko AR, Abramov VG. Botulinum toxin type A (Relatox) in the treatment of chronic migraine in adults: results of phase IIIb, randomized, one-blind, multicenter, active-controlled, parallel-group trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2023; 123 (5): 89-99. (In Russ.) https://doi.org/10.17116/jnevro202312305189

10. Aurora SK, Dodick DW, Diener HC, DeGryse RE, Turkel CC, Lipton RB, Silberstein SD. OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program. Acta Neurol Scand. 2014 Jan; 129 (1): 61-70. https://doi.org/10.1111/ane.12171. Epub 2013 Sep 20. PMID: 24107267; PMCID: PMC4033567.

11. Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives N, Clarke CE, Sinclair A. Botulinum toxins for the prevention of migraine in adults. Cochrane Database Syst Rev. 2018 Jun 25; 6 (6): CD011616. https://doi.org/10.1002/14651858.CD011616.pub2. PMID: 29939406; PMCID: PMC6513576.

12. Salnikova V.A., Antipenko E.A., Erohina M.N. Pain in muscular dystonia, the possibility of botulinum therapy. Russian Journal of Pain. 2019; 17 (1): 17-21. (In Russ.). https://doi. org/10.25731/RASP.2019.01.03

13. Nicol AL, Wu II, Ferrante FM. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design. Anesth Analg. 2014 Jun; 118 (6): 1326-35. https://doi.org/10.1213/ANE.0000000000000192. PMID: 24842179; PMCID: PMC4030686.

14. Gibson W, Wand BM, Meads C, Catley MJ, O'Connell NE. Transcutaneous electrical nerve stimulation (TENS) for chronic pain - an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2019 Apr 3; 4 (4): CD011890. https://doi.org/10.1002/14651858.CD011890. pub3. PMID: 30941745; PMCID: PMC6446021.

15. Martins-de-Sousa PH, Fidelis-de-Paula-Gomes CA, Pontes-Silva A, Henrique MFP, Araujo GGC, Kalatakis-Dos-Santos AE, Damasceno KLB, Dibai-Filho AV. Additional effect of transcutaneous electrical nerve stimulation in a therapeutic exercise program for sedentary with chronic neck pain: A double-blind randomized controlled trial. Physiother Res Int. 2023 Jan; 28 (1): e1978. https://doi.org/10.1002/pri.1978. Epub 2022 Oct 17. PMID: 36252091.

16. Dodick DW. A Phase-by-Phase Review of Migraine Pathophysiology. Headache. 2018 May; 58 Suppl 1: 4-16. https://doi.org/10.1111/head.13300. PMID: 29697154

17. Choudhury S, Baker MR, Chatterjee S, Kumar H. Botulinum Toxin: An Update on Pharmacology and Newer Products in Development. Toxins (Basel). 2021 Jan 14; 13 (1): 58. https://doi.org/10.3390/toxins13010058. PMID: 33466571; PMCID: PMC7828686.


Review

For citations:


Soskin V.M. Electrotherapy in the Combined Treatment of Patients with Chronic Migraine and Cervicalgia. Medical alphabet. 2024;(33):47-50. (In Russ.) https://doi.org/10.33667/2078-5631-2024-33-47-50

Views: 142


ISSN 2078-5631 (Print)
ISSN 2949-2807 (Online)